{
    "2019-12-29": [
        [
            {
                "time": "",
                "original_text": "天坛生物(600161.SH)：“注射用重组人凝血因子III”于近日正式开展III期临床试验",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "注射用重组人凝血因子III",
                        "III期临床试验"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}